Feasibility of maintaining near-normal glucose control in pregnant women with type 1 diabetes during COVID-19 lockdown.

Journal Information

Full Title: Acta Diabetol

Abbreviation: Acta Diabetol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Endocrinology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Conflict of interestM.M.S. has received funds from Novo Nordisk for speaker engagements. A.C. has received funds from Abbott, Lilly, Novo Nordisk, Sanofi, Menarini, Roche Diagnostics, Medtronic, Diabeloop, and Novalab as a consultant for speaker engagements or travel grants. R.C. has received funds from Abbott, Ascensia, Lilly, Medtronic, Menarini, Novo Nordisk, and Sanofi as a consultant for speaker engagements or travel grants. Conflict of interest M.M.S. has received funds from Novo Nordisk for speaker engagements. A.C. has received funds from Abbott, Lilly, Novo Nordisk, Sanofi, Menarini, Roche Diagnostics, Medtronic, Diabeloop, and Novalab as a consultant for speaker engagements or travel grants. R.C. has received funds from Abbott, Ascensia, Lilly, Medtronic, Menarini, Novo Nordisk, and Sanofi as a consultant for speaker engagements or travel grants."

Evidence found in paper:

"Funding This research received no specific grant from any funding agency in the public, commercial or not-for-profit sectors."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025